AMOEBA (EPA:ALMIB) - Amoeba : 2018 Interim Financial Report.
Transparency directive : regulatory news
26/09/2018 16:23
Click here to download pdf version
PRESS RELEASE
2018 Interim Financial Report
Chassieu, September 26st, 2018 - AMOEBA (FR0011051598 - AMEBA), producer of a
biological biocide capable of eliminating bacterial risk in water, plant
protection and wound care, announced today that it has published its Interim
Financial Report for 2018.
AMOEBA's shareholders are informed that the interim financial report for the
2018 financial year (ending on December 31st, 2018), can be found at the
company website:
http://www.amoeba-biocide.com/en/regulatories-information-and-financial-
documents
This report includes:
* Interim Activity Report
* Condensed Interim Financial Statements
* Certification of the person responsible for the interim financial report
* Statutory Auditors' Review Report on the interim financial information
About AMOEBA:
Amoéba's ambition is to become a major player in the treatment of bacterial
risk in the fields of water, healthcare and plant protection. Our biological
solution is an alternative to chemical products widely used today. Amoéba is
currently focusing on the market of industrial cooling towers estimated at
EUR1.7Bn (1) on a global chemical biocide market for water treatment, evaluated
at EUR21Bn (2) and on the biocontrol market for plant protection estimated
globally at EUR1.6Bn (4). In the future, the Company is looking at developing
new applications such as chronic wound care, estimated at EUR 751 million (3)
in the USA. Sales of associated products with healthcare, biocides and plant
protection are subject to the Company being granted local regulatory market
authorizations.
Created in 2010, based in Chassieu (Lyon, France) with a subsidiary in Canada
and in the United States, Amoéba is quoted on the compartment C of Euronext
Paris. The Company is a member of the BPIfrance Excellence network and is
eligible for the PEA-PME SME equity savings plan setup. More information on
www.amoeba-biocide.com.
(1): Amoéba data combined from sources: DRIRE 2013, Eurostat, ARHIA 2013
(2): Sources combined by Amoéba from water treaters, Freedonia, Eurostat et
MarketsandMarkets
(3): BCC Research, "Markets for Advanced Wound Management Technologies,"
Wellesley, MA, 2017
(4): Biopesticides Worldwide Market 2013, CPL, Wallingford, UK
Contacts :
Amoéba
Valérie FILIATRE
Chief Financial Officer
(33)4 26 69 16 00
valerie.filiatre@amoeba-biocide.com
Actifin
Ghislaine GASPARETTO
Communication financière
01 56 88 11 11
ggasparetto@actifin.fr